Richard U. de Schutter, Director at Durata Therapeutics, Inc. (DRTX), bought 15,000 shares at $15.57 ($234K) on 2014-05-12, disclosed to the SEC on 2014-05-14.
Open-market purchase of $234k DRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-07-03 | $218K | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |